[go: up one dir, main page]

ES2160117T3 - Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion. - Google Patents

Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.

Info

Publication number
ES2160117T3
ES2160117T3 ES94904944T ES94904944T ES2160117T3 ES 2160117 T3 ES2160117 T3 ES 2160117T3 ES 94904944 T ES94904944 T ES 94904944T ES 94904944 T ES94904944 T ES 94904944T ES 2160117 T3 ES2160117 T3 ES 2160117T3
Authority
ES
Spain
Prior art keywords
carboplatino
pharmaceutical composition
production procedure
based pharmaceutical
citostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94904944T
Other languages
English (en)
Inventor
Frantisek Kiss
Ludmila Kissova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Farmaceutika dd
Original Assignee
Pliva Farmaceutska Industrija dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Industrija dd filed Critical Pliva Farmaceutska Industrija dd
Application granted granted Critical
Publication of ES2160117T3 publication Critical patent/ES2160117T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PREPARACION MEDICA ANTITUMORAL BASADA EN UN COMPUESTO CITOSTATICO CARBOPLATINICO CUYA ESTABILIDAD A LARGO PLAZO Y ACTIVIDAD BIOLOGICA EN DISOLUCION ACUOSA CON VALOR DE PH DESDE 2.0 A 7.0, SE CONSIGUE POR LA PRESENCIA DEL ACIDO 1,1CICLOBUTANODICARBOXILICO Y/O SODIO Y/O POTASIO Y/O SALES AMONICAS Y/O COMPUESTOS AUXILIARES FARMACEUTICAMENTE ACEPTABLES Y METODO DE PRODUCCION SEGUIDO.
ES94904944T 1994-02-07 1994-02-07 Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion. Expired - Lifetime ES2160117T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CZ1994/000007 WO1995020956A1 (en) 1994-02-07 1994-02-07 Anti-tumour medical preparation on the basis of carboplatin and the method of its production

Publications (1)

Publication Number Publication Date
ES2160117T3 true ES2160117T3 (es) 2001-11-01

Family

ID=5469133

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94904944T Expired - Lifetime ES2160117T3 (es) 1994-02-07 1994-02-07 Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.

Country Status (5)

Country Link
EP (1) EP0743854B1 (es)
AU (1) AU5878294A (es)
DE (1) DE69427595T2 (es)
ES (1) ES2160117T3 (es)
WO (1) WO1995020956A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
CN1121380C (zh) 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
RU2219183C2 (ru) * 2000-03-03 2003-12-20 Зукин ЯН Производное комплекса удвоенная дикарбоновая кислота-диаминоплатина, способ его получения, противоопухолевая фармацевтическая композиция и использование этого производного
AU2003248060A1 (en) 2003-07-11 2005-01-28 Shishiai-Kabushikigaisha Cooling fluid composition for fuel battery
PL3826613T3 (pl) * 2018-08-31 2025-04-07 Sun Pharmaceutical Industries Limited Pozajelitowa postać dawkowania karboplatyny
US12427104B1 (en) 2025-04-01 2025-09-30 Ingenus Pharmaceuticals, Llc Injectable carboplatin formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605550A5 (es) * 1972-06-08 1978-09-29 Research Corp
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
IL85790A0 (en) * 1988-03-20 1988-09-30 Abic Ltd Solution of carboplatin
JPH0667834B2 (ja) * 1989-03-09 1994-08-31 二郎 藤本 抗腫瘍剤
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.

Also Published As

Publication number Publication date
WO1995020956A1 (en) 1995-08-10
AU5878294A (en) 1995-08-21
DE69427595T2 (de) 2002-04-25
DE69427595D1 (de) 2001-08-02
EP0743854B1 (en) 2001-06-27
EP0743854A1 (en) 1996-11-27

Similar Documents

Publication Publication Date Title
SE8804629D0 (sv) New therapeutically active compounds
DK275488A (da) Indolonderivater
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
YU126186A (en) Process for making water gelating solutions of arylpropionic acid derivatives, which can be respirated through skin
BR9709845A (pt) Preparação aquosa de insulina formulação farmacêutica parenteral e processo para aumentar a estabilidade química de uma preparação de insulina
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
ES2160117T3 (es) Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.
PH27446A (en) Compound with gastric acid inhibitory effect
SE8704952D0 (sv) Farmaceutisk komposition
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
CO4980849A1 (es) Composiciones farmaceuticas -2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona(la mivudina), y su uso en terapia medica
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
IT1214658B (it) Esteri polisaccaridici e loro sali
FR2681075B1 (fr) Preparation enzymatique purifiee issue de chromobacterium violaceum, son procede d'obtention et son application a la production d'alpha,beta-dehydrotryptophanyl-peptides.
GR3018126T3 (en) 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent.
IT1203815B (it) Esteri polisaccaridici e loro sali
ES2038588T3 (es) Procedimiento para la obtencion de nuevos semihidratos cristalinos del 3-metoxi-4-(4'-aminobencenosulfonamido)-1,2,5-tiadiazol.
DK493887A (da) Buccal formulering

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 743854

Country of ref document: ES